UNIVERSITA' DEGLI STUDI DI MILANO-BICOCCA

Their core work

Milano-Bicocca is a major Italian research university with deep strengths in computational biology, nanomedicine, and mathematical physics. Their teams develop bioinformatics tools for pan-genomics and genome data science, design nanoparticle-based drug delivery systems to cross biological barriers, and pursue fundamental research in quantum field theory and integrable systems. Beyond pure research, they actively contribute to research infrastructure training, social inequality studies, and digital innovation projects including business data analytics and Industry 4.0.

What they specialise in

How they've shifted over time

In the early H2020 period (2014–2018), UNIMIB focused heavily on nanomedicine (nanoparticle drug delivery, biological barriers), social inequality and human capital research, and building research infrastructure capacity. From 2019 onward, a clear pivot toward computational biology is visible — bioinformatics, pan-genomics, graph algorithms, and genome data science dominate recent keywords, alongside growing involvement in digitization, cyber-physical systems, and gender studies. This signals a university repositioning itself at the intersection of data science and life sciences.

UNIMIB is rapidly building capacity in algorithmic bioinformatics and genome data science, making them an increasingly strong partner for projects combining computational methods with biological applications.

How they like to work

With 34 coordinated projects out of 89 (38%), UNIMIB is a confident project leader, especially in MSCA training networks and ERC grants where they take the principal investigator role. Their 906 unique partners across 49 countries indicate a hub organization that builds new connections rather than recycling the same consortium. This makes them easy to approach for new partnerships — they are accustomed to integrating into diverse, large-scale consortia while also running their own research agendas.

UNIMIB has collaborated with 906 unique organizations across 49 countries, making them one of the more extensively networked Italian universities in H2020. Their partnerships span all of Europe with strong connections to institutions in social sciences, life sciences, and physics research communities.

What sets them apart

UNIMIB stands out for the breadth of its research portfolio — few universities combine algorithmic bioinformatics, nanomedicine, mathematical physics, and social inequality research at this level of EU funding. Their high coordinator rate (38%) shows they can lead complex projects, not just contribute. For consortium builders, UNIMIB offers the rare ability to bridge computational and experimental work, particularly where genome data science meets biomedical applications.

Highlights from their portfolio

• BIOINOHYB
  Largest coordinated project at €1.75M, developing smart bioinorganic hybrid nanomaterials for medicine — showcases their nanomedicine leadership.
• HBQFTNCER
  ERC-funded project (€1.25M) in quantum field theory, demonstrating world-class fundamental research capability in mathematical physics.
• RItrain
  Coordinated a €912K programme training the next generation of research infrastructure leaders — shows institutional commitment beyond bench science.